Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical insulin for postoperative wound healing in diabetic laparotomy patients
IRCT20230116057136N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of human insulin in Surgical wound (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Infection and purulent discharge, Pain and 6 more. Started May 2023; status: completed.
02
Drugs
human insulin
03
Conditions
Surgical wound
Beyond the preview
Go deeper on IRCT20230116057136N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230116057136N1.